These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Separation and purification of ribonucleic acid (RNA) from rat-liver extracts. BASSIR O Biochem J; 1954 Dec; 59(335th Meeting):xv. PubMed ID: 14351217 [No Abstract] [Full Text] [Related]
29. Nutritional supplementation with amino acids in cardiovascular and metabolic diseases: hypermetabolic syndrome as a therapeutic target. Introduction. Gheorghiade M; Filippatos GS; Fonarow GC; Anker SD Am J Cardiol; 2008 Jun; 101(11A):1E-2E. PubMed ID: 18514617 [No Abstract] [Full Text] [Related]
30. Amino acid composition and antioxidative peptides from protein hydrolysates of yellow stripe Trevally (Selaroides leptolepis). Klompong V; Benjakul S; Yachai M; Visessanguan W; Shahidi F; Hayes KD J Food Sci; 2009 Mar; 74(2):C126-33. PubMed ID: 19323726 [TBL] [Abstract][Full Text] [Related]
31. [Possibilities of an amino acid therapy with bioprotin in the first vear of life]. GROSS H Wien Med Wochenschr; 1959 Mar; 109(12):257-8. PubMed ID: 13648407 [No Abstract] [Full Text] [Related]
32. Influence of amino acid therapy in chronic idiopathic pruritus ani. LEVINE AJ; DAVIS OF; HORWITZ B; SLOAN N; BECK C Gastroenterology; 1958 Oct; 35(4):409-13. PubMed ID: 13586548 [No Abstract] [Full Text] [Related]
33. An introduction to amino acids. Berliner S Adv Nurse Pract; 2006 May; 14(5):47-8, 82. PubMed ID: 16972426 [No Abstract] [Full Text] [Related]
34. [Amino acid tolerance test in dystrophic infants]. BRUSA P; QUINTE V Minerva Pediatr; 1955 Feb; 7(8):209-19. PubMed ID: 14369904 [No Abstract] [Full Text] [Related]
35. [Amino acid supplement & nitrogen retention in dystrophic infants]. SUAREZ M; GARCIA-VIDAL E Rev Esp Pediatr; 1957; 13(75):279-300. PubMed ID: 13466455 [No Abstract] [Full Text] [Related]
36. [Quantitative paper chromatography of amino acids in protein hydrolysates]. KOFRANYI E Hoppe Seylers Z Physiol Chem; 1955; 299(3-4):129-38. PubMed ID: 14391832 [No Abstract] [Full Text] [Related]
37. [Clinical characteristic of hydrolysin L-103]. ZVIAGIN LM; NARBUT EI Vestn Khir Im I I Grek; 1958 Aug; 81(8):50-4. PubMed ID: 13593114 [No Abstract] [Full Text] [Related]
38. [Use of L-103 hydrolysin in malignant tumors]. ROZHEK IS Vopr Onkol; 1959; 5(5):582-6. PubMed ID: 13669407 [No Abstract] [Full Text] [Related]
39. [Treatment of atherosclerosis with the compound 67-82]. ROUZAUD C Gaz Med Fr; 1959 Jun; 66(12):1115-9. PubMed ID: 13672365 [No Abstract] [Full Text] [Related]
40. Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans. Calbet JA; Holst JJ Eur J Nutr; 2004 Jun; 43(3):127-39. PubMed ID: 15168035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]